Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-11SPRY144ERIC KARAS plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
ERIC KARAS filed Form 144 to notify SEC of plan to sell 14064 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-11, with aggregate market value of $69,761.66. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 mo...
Small CapBiotechnology
2026-09-11SPRY144RICHARD LOWENTHAL plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
RICHARD LOWENTHAL filed Form 144 to notify SEC of plan to sell 35000 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-11, with aggregate market value of $176,995.00. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.04% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-09-11AARD144NELSON SUN plan to sell securities of AARDVARK THERAPEUTICS INC under Form 144MEDIUM
NELSON SUN filed Form 144 to notify SEC of plan to sell 33911 units of AARDVARK THERAPEUTICS INC securities around 2026-09-11, with aggregate market value of $169,894.11. The total outstanding units is 21884846.0. The amount planned to be sold represents 0.15% of total outstanding units; Recent transactions in past 3 m...
Micro CapBiotechnology
2026-09-11AMLX144Cohen Joshua B plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Cohen Joshua B filed Form 144 to notify SEC of plan to sell 30464 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $980,504.00. The total outstanding units is 3613123.0. The amount planned to be sold represents 0.84% of total outstanding units; ...
Mid CapBiotechnology
2026-09-11AMLX144Mazzariello Gina plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Mazzariello Gina filed Form 144 to notify SEC of plan to sell 9536 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $309,506.00. The total outstanding units is 190838.0. The amount planned to be sold represents 5.00% of total outstanding units; Recent transactions in pa...
Mid CapBiotechnology
2026-09-11AMLX144Bedrosian Camille L plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Bedrosian Camille L filed Form 144 to notify SEC of plan to sell 10028 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $324,868.00. The total outstanding units is 278064.0. The amount planned to be sold represents 3.61% of total outstanding units; ...
Mid CapBiotechnology
2026-09-11AMLX144Frates James M plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Frates James M filed Form 144 to notify SEC of plan to sell 10810 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $349,821.00. The total outstanding units is 233625.0. The amount planned to be sold represents 4.63% of total outstanding units; ...
Mid CapBiotechnology
Sponsored
2026-09-11AMLX144Klee Justin B. plan to sell securities of Amylyx Pharmaceuticals, Inc. under Form 144MEDIUM
Klee Justin B. filed Form 144 to notify SEC of plan to sell 30464 units of Amylyx Pharmaceuticals, Inc. securities around 2026-09-10, with aggregate market value of $980,264.00. The total outstanding units is 3613056.0. The amount planned to be sold represents 0.84% of total outstanding units; ...
Mid CapBiotechnology